Work

Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience

Year: 2020

Type: article

Study design: Observational Study

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2020.1775214

Authors: Armon Azizi, Asiri Ediriwickrema, Ritika Dutta, Shyam A. Patel, William Shomali, Bruno Medeiros, David Iberri, Jason Gotlib, Gabriel Mannis, Peter Greenberg, Ravindra Majeti, Tian Zhang

Institutions: Stanford Medicine, Stanford Cancer Institute, Stanford University, University of Massachusetts Chan Medical School, UMass Memorial Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: A.P. Giannini Foundation, National Cancer Institute

Award: Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML

OpenAlex ID: W3035312513

FWCI: 3.315

Cites: 27

Cited by: 28

Related to: 10